Core Scientific, Inc/tx Form 4 insider transactions

CoreWeave, Inc. filed a Form 425 communication on LinkedIn regarding its proposed acquisition of Core Scientific, Inc., directing stakeholders to comprehensive SEC filings for detailed transaction information.

CoreWeave, Inc. and Core Scientific, Inc. announced a proposed acquisition, aiming to combine capabilities to meet surging customer demand for AI computing infrastructure, with an expected closing in Q4 2025.

CoreWeave, Inc. has filed a Form 425 with the SEC regarding its proposed acquisition of Core Scientific, Inc., providing essential information for investors and security holders on the transaction.

CoreWeave, a leading data center operator, announced its $9 billion all-stock acquisition of long-standing partner Core Scientific to expand its high-performance computing infrastructure for AI clients.

CoreWeave's CEO, Michael Intrator, posted a LinkedIn update on the proposed acquisition of Core Scientific, emphasizing the need for investors to review official SEC filings for detailed transaction information and outlining associated risks.

CoreWeave, a leading AI cloud platform provider, announced its acquisition of Core Scientific to deepen vertical integration and enhance its high-performance computing infrastructure.

CoreWeave, Inc. has announced a definitive agreement to acquire Core Scientific, Inc., a leading data center infrastructure provider and close partner, marking a significant strategic expansion.

CoreWeave, Inc. has filed a Form 425 communication regarding its proposed acquisition of Core Scientific, Inc., emphasizing the need for investors to review forthcoming SEC filings detailing the transaction and associated risks.

CoreWeave announced an agreement to acquire Core Scientific in an all-stock transaction valued at $9 billion, aiming to significantly expand its AI and HPC infrastructure, enhance operational efficiencies, and reduce capital costs.

CoreWeave announced its proposed all-stock acquisition of Core Scientific, aiming to enhance its AI and high-performance computing capabilities by gaining direct control over critical data center infrastructure and achieving significant cost efficiencies.

CoreWeave, Inc. has formally communicated its proposed acquisition of Core Scientific, Inc., outlining the required SEC filings and a comprehensive list of transaction-related risks.

Core Scientific has signed a definitive agreement to be acquired by CoreWeave in an all-stock transaction valued at approximately $9 billion, positioning the combined entity to accelerate AI infrastructure development.

Core Scientific announced an agreement to be acquired by CoreWeave in an all-stock transaction valued at approximately $9.0 billion, positioning the combined entity to accelerate world-class AI infrastructure.

Core Scientific announced its definitive agreement to be acquired by CoreWeave in an all-stock transaction, marking a strategic shift from bitcoin mining to high-density colocation infrastructure for AI.

Core Scientific, a leading blockchain infrastructure company, has entered into a definitive merger agreement to be acquired by CoreWeave, a specialized cloud provider, in an all-stock transaction at an exchange ratio of 0.1235 shares of CoreWeave Class A common stock for each Core Scientific share.

CoreWeave will acquire Core Scientific in an all-stock transaction valued at approximately $9.0 billion, aiming to verticalize data center ownership and accelerate AI and HPC workload deployment.

Core Scientific CEO Adam Taylor Sullivan reported the disposition of 23,508 shares of common stock to cover tax obligations from restricted stock unit vesting, alongside a previously acquired 4,912 shares from an in-kind distribution.

Core Scientific's Chief Legal and Administrative Officer, Todd DuChene, reported the disposition of 8,228 shares of common stock at $17.07 per share to cover tax withholding obligations related to restricted stock unit vesting.

Core Scientific's Chief Legal and Administrative Officer, Todd M. DuChene, sold 7,759 shares of common stock to cover tax obligations related to restricted stock unit vesting, while also receiving 7,346 shares from a bankruptcy claims settlement.

Core Scientific's Chief Legal and Administrative Officer, Todd M. DuChene, sold 50,000 shares of common stock for approximately $12.31 per share on June 4, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Core Scientific's Chief Legal and Administrative Officer, Todd M. DuChene, sold 60,000 shares of common stock for approximately $680,000 under a Rule 10b5-1 trading plan.

Core Scientific, Inc. Director Elizabeth Crain was granted 46,773 restricted stock units (RSUs) as part of her compensation, vesting in full on May 14, 2028.

A recent SEC Form 4 filing reveals that Yadin Rozov, a Director at Core Scientific, Inc., has acquired 110,000 shares of the company's common stock.

Core Scientific's Chief Legal and Administrative Officer, Todd M. DuChene, sold 50,000 shares of common stock on May 27, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., received a grant of 194,600 shares of common stock on April 28, 2025.

Core Scientific's CEO, Adam Sullivan, was granted 665,985 restricted stock units (RSUs) on April 28, 2025, according to a Form 4 filing.

Core Scientific's CEO, Adam Taylor Sullivan, sold 22,629 shares of common stock on April 1, 2025, to satisfy tax obligations related to vesting restricted stock units.

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, sold 7,921 shares of common stock on April 1, 2025, to satisfy tax obligations related to vesting restricted stock units.

James P. Nygaard Jr., EVP and CFO of Core Scientific, Inc., reports acquiring 819,672 shares of common stock through a restricted stock unit grant.

Director Eric Stanton Weiss of Core Scientific, Inc. purchased 6,000 shares of common stock at a price of $8.4584 on March 6, 2025.